CR20190211A - Modulador del regulador de conductancia de transmembrana de fibrosis quistica, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador - Google Patents

Modulador del regulador de conductancia de transmembrana de fibrosis quistica, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador

Info

Publication number
CR20190211A
CR20190211A CR20190211A CR20190211A CR20190211A CR 20190211 A CR20190211 A CR 20190211A CR 20190211 A CR20190211 A CR 20190211A CR 20190211 A CR20190211 A CR 20190211A CR 20190211 A CR20190211 A CR 20190211A
Authority
CR
Costa Rica
Prior art keywords
modulator
methods
making
pharmaceutical compositions
cystic fibrosis
Prior art date
Application number
CR20190211A
Other languages
English (en)
Inventor
Jason Mccartney
Corey Anderson
Thomas Cleveland
Pramod Virupax Joshi
Jinglan Zhou
Minson Baek
Bryan A Frieman
Brett Bradley Busch
David Andrew Siesel
Ali Keshavarz-Shokri
Rachel Mcauley-Aoki
Goor Fredrick Van
Andreas P Termin
Prasuna Paraselli
Peter Grootenhuis
Robert M Hughes
Timothy Alcacio
Ruah Sara Sabina Hadida
Beili Zhang
Paul John Krenitsky
Johnny Uy
Haripada; Khatuya
Vito; Melillo
Mark Thomas Miller
Fabrice Jean Denis Pierre
Alexander Russell Abela
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Priority claimed from PCT/US2017/054611 external-priority patent/WO2018064632A1/en
Publication of CR20190211A publication Critical patent/CR20190211A/es

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CR20190211A 2016-09-30 2017-09-29 Modulador del regulador de conductancia de transmembrana de fibrosis quistica, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador CR20190211A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662402838P 2016-09-30 2016-09-30
US201662410353P 2016-10-19 2016-10-19
US201662415409P 2016-10-31 2016-10-31
PCT/US2017/054611 WO2018064632A1 (en) 2016-09-30 2017-09-29 Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

Publications (1)

Publication Number Publication Date
CR20190211A true CR20190211A (es) 2019-07-11

Family

ID=67910532

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20190211A CR20190211A (es) 2016-09-30 2017-09-29 Modulador del regulador de conductancia de transmembrana de fibrosis quistica, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador

Country Status (1)

Country Link
CR (1) CR20190211A (es)

Similar Documents

Publication Publication Date Title
ZA202206810B (en) Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
SA519401446B1 (ar) مُعدِّل منظم التوصيل عبر الأغشية للتليف الكيسي، تركيبات صيدلية، طرق علاج، وعملية لتحضير المُعدِّل
UY38093A (es) Moduladores del regulador de conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso de preparación de los moduladores
CO2021014204A2 (es) Agentes moduladores del regulador de la conductancia transmembrana de la fibrosis quística
GEAP201914680A (en) New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them
CR20190211A (es) Modulador del regulador de conductancia de transmembrana de fibrosis quistica, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador
TN2018000175A1 (en) Indane derivatives as mglur7 modulators
EA201990850A1 (ru) Модулятор муковисцидозного трансмембранного регулятора проводимости, фармацевтические композиции, способы лечения и способы получения модулятора
NZ754805B2 (en) Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator